A medical service provider in the area of women’s health and pediatrics MD Medical Group Investments launched an in-vitro fertilization clinic in the city of Yaroslavl, Russia. The new facility, named Mother and Child Yaroslavl is MD Medical Group’s eleventh facility offering in-vitro fertilization services. The group now operates 17 ultra-modern medical clinics in Russia altogether. The medical facility is expected to provide a full spectrum of women’s services, including in-vitro fertilization and gynecology. Physicians at all of the group’s clinics have world-class ratings, and their other members of personnel are highly-trained and qualified.

The 800-square-meter clinic will become the only facility in Yaroslavl to offer advanced expertise in in-vitro fertilization. The facility’s technological platform will allow for as many as one thousand cycles of in-vitro fertilization a year. The clinic is designed to handle 20,000 patients annually. The group’s investment in the clinic’s construction stood at around USD1.5 million.

Talking about the successful launch of the clinic in Yaroslavl, the chief executive officer of MD Medical Elena Mladova stated that the company was standing behind its promise to provide exceptional and qualified medical services to patients in various regions of Russia.

Ms. Mladova indicated that the company stays concentrated on assessing every possible prospect for the MD Medical Group to grow its presence and make firm its leadership position on the market.